Systemic Diseases and Gastrointestinal Cancer Risk

J Cancer Allied Spec. 2023 Aug 13;9(2):473. doi: 10.37029/jcas.v9i2.473. eCollection 2023.

Abstract

Importance: Gastrointestinal (GI) cancers are the second leading cause of cancer-related deaths worldwide.

Observations: The global challenges GI cancers pose are high, especially in middle- and low-income countries. Patients with these cancers present with symptoms of poor appetite, weight loss, heartburn, abdominal pain, fatigue and anaemia. Several risk factors contribute to GI cancers, including age, gender, obesity, pathogenic infections, smoking cigarettes, alcohol consumption and dietary habits. Most of these cancers are sporadic. However, some patients are at high risk due to a family history of GI cancers. Systemic diseases affect multiple organs, and their chronic occurrence elicits inflammatory responses at various sites. These diseases also contribute to GI cancers.

Conclusion and relevance: In this review, we discuss that untreated systemic diseases, including diabetes, hepatitis, acquired immune deficiency syndrome, ulcers and hypertension, can potentially lead to GI cancers if they remain untreated for a longer period. Systemic diseases initiate oxidative stress, inflammatory pathways and genetic manipulations, which altogether confer risks to GI cancers. Here, we describe the association between systemic diseases and their underlying mechanisms leading to GI cancers.

Keywords: Epidemiology; gastrointestinal cancer; global burden; inflammation; risk factors.

Publication types

  • Review